microbiolog
laboratori
tradit
reli
upon
phenotyp
method
involv
cultur
biochem
test
identifi
character
clinic
import
pathogen
techniqu
sever
disadvantag
includ
poor
sensit
long
turnaround
time
molecular
mass
spectroscopi
techniqu
rapidli
chang
infect
diagnosi
manag
compar
convent
culturebas
techniqu
modern
approach
provid
substanti
rapid
specif
inform
organ
identif
presenc
resist
mechan
method
expect
contribut
substanti
enhanc
antibiot
stewardship
improv
time
appropri
antibiot
one
import
factor
improv
prognosi
patient
lifethreaten
infect
articl
give
overview
practic
applic
newer
technolog
molecular
method
nucleic
acid
amplif
test
naat
mass
spectrometri
two
common
approach
adopt
clinic
laboratori
routin
detect
identif
organ
method
also
allow
rapid
identif
microbi
sequenc
confer
drug
resist
potenti
overcom
shortcom
tradit
culturebas
method
sever
limit
tradit
culturebas
techniqu
follow
turnaround
time
e
tradit
techniqu
reli
upon
growth
pure
bacteria
primari
sampl
eg
sputum
blood
urin
incub
agar
plate
despit
supplement
growth
media
variou
enrich
factor
sampl
requir
hour
incub
may
hour
specimen
collect
biochem
identif
antimicrobi
suscept
test
complet
patient
receiv
empir
antibiot
base
best
guess
principl
interven
period
usual
broadspectrum
agent
patient
often
present
nonspecif
lead
inappropri
unnecessari
treatment
drive
antimicrobi
resist
noncultur
organ
e
rang
fastidi
organ
unlik
grow
use
tradit
cultur
includ
bartonella
borrelia
brucella
campylobact
helicobact
coxiella
legionella
leptospira
mycobacterium
nocardia
rickettsia
detect
organ
depend
upon
serolog
antigen
detect
naat
test
inhibit
suppress
antibiot
e
patient
often
given
antibiot
suppress
growth
pathogen
obtain
sampl
microbiolog
analysi
eg
administr
thirdgener
cephalosporin
suspect
bacteri
mening
obtain
cerebrospin
fluid
csf
sampl
blood
cultur
system
manufactur
supplement
media
proprietari
formul
antibioticbind
resin
bead
minim
problem
variabl
result
e
tradit
microbiolog
base
pattern
recognit
interpret
visual
appear
morpholog
organ
eg
gram
stain
despit
use
standard
oper
procedur
oper
depend
reliant
upon
subject
judgement
autom
molecular
techniqu
help
standard
reduc
error
result
variat
report
poor
sensit
e
bacteri
cultur
depend
critic
mass
viabl
organ
surviv
transport
amount
live
bacteria
primari
specimen
low
signific
proport
surviv
transport
process
low
sensit
may
experienc
molecular
techniqu
enhanc
sensit
amplifi
stretch
bacteri
nucleic
acid
lower
number
target
bacteria
need
optim
transport
condit
also
less
critic
sinc
nucleic
acid
detect
dead
cell
naat
polymeras
chain
reaction
pcr
relat
technolog
reli
amplif
replic
specif
sequenc
later
detect
usual
fluoresc
probe
name
pcr
deriv
fact
dna
polymeras
enzym
eg
taq
respons
dna
synthesi
chain
reaction
mean
exponenti
growth
rate
n
n
denot
number
gener
figur
follow
exampl
practic
use
molecular
techniqu
modern
microbiolog
laboratori
mycobacterium
tuberculosi
slow
grow
often
take
week
microscop
examin
specimen
ziehleneelsen
auramin
stain
simpl
perform
rapid
poorli
sensit
patient
pulmonari
tuberculosi
tb
smearposit
differenti
tuberculosi
nontubercul
mycobacteria
avium
complex
etc
pcr
test
avail
use
smearposit
neg
sampl
detect
tb
hour
cepheid
genexpert
system
advantag
detect
rpob
gene
confer
rifampicin
resist
marker
multidrug
resist
england
programm
mandat
patient
admit
hospit
screen
mrsa
found
posit
isol
given
topic
suppress
therapi
may
given
antibiot
prophylaxi
requir
certain
type
surgeri
tradit
cultur
take
hour
time
may
uncertainti
manag
patient
particularli
present
unplan
emerg
admiss
use
commerci
avail
naat
reduc
turnaround
time
inappropri
preemptiv
isol
associ
cost
gold
standard
method
detect
anaerob
organ
slow
labour
intens
requir
access
cell
cultur
facil
demonstr
cytotoxigen
laboratori
quickli
adopt
enzym
immunoassay
direct
detect
toxin
b
stool
sampl
becam
avail
simplifi
procedur
allow
result
obtain
within
around
hour
unfortun
sensit
mani
commerci
avail
test
suboptim
health
protect
agenc
recommend
use
twostag
test
algorithm
may
incorpor
molecular
test
sever
avail
help
improv
accuraci
diagnosi
molecular
test
detect
presenc
gene
rather
gene
express
import
correl
test
result
clinic
find
help
differenti
colon
may
detect
around
hospit
patient
infect
chlamydia
cultur
technic
demand
poorli
sensit
wherea
gonorrhoea
cultur
simpler
still
lack
sensit
molecular
test
allow
use
less
invas
sampl
eg
urin
rather
urethr
swab
patient
may
prefer
coinfect
common
multiplex
molecular
test
allow
detect
two
pathogen
sampl
introduc
pointofcar
test
potenti
reduc
unnecessari
preemptiv
treatment
well
requir
patient
reattend
clinic
cost
save
perform
test
clinic
avoid
delay
sampl
transport
bottleneck
batch
central
laboratori
sepsi
high
excess
mortal
increas
approxim
everi
hour
antibiot
delay
symptom
sepsi
often
nonspecif
blood
cultur
frequent
fail
identifi
caus
organ
sever
commerci
test
detect
blood
stream
infect
eg
sepsitest
molzym
bremen
germani
vyoo
sirslab
jena
germani
lightcycl
septifast
roch
mannheim
germani
could
help
guid
antibiot
therapi
accur
howev
current
avail
test
lack
suffici
sensit
specif
requir
specimen
batch
minimum
hour
process
time
technic
complex
sever
pathogen
may
respons
symptom
may
benefici
appli
molecular
test
panel
multipl
target
rather
perform
individu
test
sequenti
sever
molecular
technolog
particularli
suit
multiplex
eg
luminex
xtag
seegen
seeplex
biofir
filmarray
commerci
product
allow
detect
target
one
test
allow
differenti
pathogen
caus
similar
symptom
eg
gastroenter
respiratori
tract
infect
mening
approach
simplifi
test
request
minim
chanc
infect
miss
failur
request
correct
pathogen
test
significantli
faster
tradit
method
cultur
campylobact
salmonella
shigella
take
day
allow
effici
use
side
room
reaction
cool
around
allow
synthet
primer
anneal
complementari
site
separ
dna
strand
reaction
heat
around
polymeras
extend
two
primer
opposit
direct
doubl
number
target
strand
process
repeat
make
billion
copi
cycl
univers
broad
rang
pcr
often
unclear
pathogen
respons
diseas
sampl
may
difficult
obtain
may
limit
amount
avail
test
eg
csf
tissu
sampl
obtain
surgeri
molecular
techniqu
requir
request
know
look
probe
primer
specif
particular
organ
design
pcr
allow
detect
broad
rang
bacteria
fungi
respect
use
gene
sequenc
contain
hypervari
region
provid
speciesspecif
signatur
sequenc
molecular
method
allow
sequenc
bacteri
genom
includ
whole
genom
sequenc
nextgener
techniqu
allow
whole
genom
sequenc
organ
hour
cost
around
price
continu
fall
rapidli
develop
area
rich
result
data
allow
detect
virul
determin
antimicrobi
resist
well
indepth
studi
epidemiolog
diseas
particularli
benefici
investig
outbreak
infect
character
newli
emerg
pathogen
novel
coronaviru
ncov
caus
sever
respiratori
infect
techniqu
use
laser
ioniz
acceler
bacteri
fungal
molecul
separ
accord
masstocharg
ratio
reach
detector
end
instrument
differ
time
way
molecul
yield
distinct
signal
compar
databas
known
organ
provid
identif
speci
level
highli
accur
inexpens
initi
outlay
cost
result
avail
pure
coloni
minut
malditof
also
use
direct
identif
bacteria
yeast
isol
blood
cultur
broth
detect
phenotyp
antimicrobi
resist
analysi
bacteri
metabolit
abbott
plexid
system
coupl
upfront
pcr
electron
spray
mass
spectrometri
result
amplicon
piec
dnarna
gener
pcr
provid
identif
without
need
prior
cultur
organ
yield
result
approxim
hour
move
toward
reorgan
consolid
patholog
laboratori
improv
effici
qualiti
may
drive
forc
adopt
newer
techniqu
could
potenti
open
new
model
diagnost
test
exampl
pointofcar
nearpati
diagnost
technolog
develop
diagnost
compani
offer
increas
choic
cost
multiplex
capabl
like
improv
speed
cost
whole
genom
sequenc
includ
deep
sequenc
analys
whole
popul
organ
rapidli
improv
techniqu
like
adopt
routin
practic
near
futur
comput
power
bioinformat
avail
analys
result
data
like
limit
factor
widespread
adopt
although
techniqu
offer
sever
clear
advantag
must
balanc
addit
cost
expertis
technolog
requir
addit
techniqu
allow
easi
archiv
sampl
futur
studi
bacteria
normal
isol
pure
cultur
could
limit
epidemiolog
surveil
e
exampl
mani
laboratori
send
varieti
isol
public
health
england
type
techniqu
natur
genom
give
inform
whether
particular
gene
express
must
born
mind
interpret
result
